中文 | English
Return
Total: 342 , 1/35
Show Home Prev Next End page: GO
Author:(Xing-yue ZHANG)

1.Enzyme-directed Immobilization Strategies for Biosensor Applications

Xing-Bao WANG ; Yao-Hong MA ; Yun-Long XUE ; Xiao-Zhen HUANG ; Yue SHAO ; Yi YU ; Bing-Lian WANG ; Qing-Ai LIU ; Li-He ZHANG ; Wei-Li GONG

Progress in Biochemistry and Biophysics 2025;52(2):374-394

3.Study on fluvoxamine maleate sustained-release pellets and its compression technology

Ming-hui XU ; Xing-yue ZHANG ; Qiao DONG ; Xia ZHAO ; Yu-ru BU ; Le-zhen CHEN

Acta Pharmaceutica Sinica 2024;59(2):439-447

4.A study on the job preferences and heterogeneity of medical students from different birthplaces:A discrete choice experiment based on six hospitals in Beijing

Xin-Yan LI ; Yue ZHANG ; Yu-Xin SUN ; Xing LIN ; You-Li HAN

Chinese Journal of Health Policy 2024;17(1):51-59

5.Clinical progress in the diagnosis and treatment of end-stage liver disease complicated with acute kidney injury

Jingjing LU ; Yangyang HU ; Xing ZHANG ; Yue LUO ; Yadong WANG ; Caiyan ZHAO

Chinese Journal of General Practitioners 2024;23(3):314-319

6.A unicenter real-world study of the correlation factors for complete clinical response in idiopathic inflammatory myopathies

Zhanhong LAI ; Jiachen LI ; Zelin YUN ; Yonggang ZHANG ; Hao ZHANG ; Xiaoyan XING ; Miao SHAO ; Yue-Bo JIN ; Naidi WANG ; Yimin LI ; Yuhui LI ; Zhanguo LI

Journal of Peking University(Health Sciences) 2024;56(2):284-292

7.Analysis of the current situation, advantages and difficulties of standardized management of Investigator Initiated Clinical Trials

Yingshuo HUANG ; Xu ZUO ; Yue LI ; Lihan XING ; Shuilong GUO ; Zhenchang WANG ; Shutian ZHANG

Chinese Journal of Medical Science Research Management 2024;37(1):70-74

8.RgpB contributes to chemoresistance in esophageal squamous cell carcinoma by preventing Cx43 degradation via inhibiting autophagosome-lysosome fusion

Yue DU ; Xiusen ZHANG ; Kexu ZHOU ; Xing JIN ; Xiang YUAN ; Shegan GAO

Journal of Southern Medical University 2024;44(9):1670-1676

9.POLG inhibitor suppresses migration and invasion of triple-negative breast cancer cells via blocking mitochondrial biogenesis

Xing LIU ; Shuangqin FAN ; Xiaomin YAN ; Shijie ZHAO ; Rong WANG ; Xiangchun SHEN ; Xue ZHOU ; Yue ZHANG ; Yan CHEN

Acta Universitatis Medicinalis Anhui 2024;59(10):1720-1728

10.Efficacy and safety of camrelizumab monoclonal antibody combined with molecular-targeted therapy in elderly patients with advanced hepatocellular carcinoma

Long CHENG ; Yue ZHANG ; Yushen LIU ; Zhaoqing DU ; Zhaoyang GUO ; Yangwei FAN ; Ting LI ; Xu GAO ; Enrui XIE ; Zixuan XING ; Wenhua WU ; Yinying WU ; Mingbo YANG ; Jie LI ; Yu ZHANG ; Wen KANG ; Wenjun WANG ; Fanpu JI ; Jiang GUO ; Ning GAO

Journal of Clinical Hepatology 2024;40(10):2034-2041

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 342 , 1/35 Show Home Prev Next End page: GO